Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

EIDX

Eidos Therapeutics (EIDX)

Eidos Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:EIDX
DateTimeSourceHeadlineSymbolCompany
06/02/202108:32Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:EIDXEidos Therapeutics Inc
28/01/202122:05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:EIDXEidos Therapeutics Inc
27/01/202108:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:EIDXEidos Therapeutics Inc
27/01/202101:01Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:EIDXEidos Therapeutics Inc
27/01/202100:48Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:EIDXEidos Therapeutics Inc
27/01/202100:47Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EIDXEidos Therapeutics Inc
27/01/202100:30GlobeNewswire Inc.BridgeBio Pharma, Inc. Announces Completion of Merger with Eidos Therapeutics, Inc.NASDAQ:EIDXEidos Therapeutics Inc
21/01/202108:23Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EIDXEidos Therapeutics Inc
20/01/202108:01GlobeNewswire Inc.Stockholders of BridgeBio Pharma, Inc. and Eidos Therapeutics, Inc. Approve BridgeBio Pharma, Inc. Acquisition of Eidos Thera...NASDAQ:EIDXEidos Therapeutics Inc
16/01/202108:06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:EIDXEidos Therapeutics Inc
14/01/202108:50Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:EIDXEidos Therapeutics Inc
14/01/202108:30GlobeNewswire Inc.BridgeBio Pharma, Inc. and Eidos Therapeutics, Inc. Announce January 21, 2021 Election Deadline for MergerNASDAQ:EIDXEidos Therapeutics Inc
12/01/202123:43Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:EIDXEidos Therapeutics Inc
12/01/202123:32Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:EIDXEidos Therapeutics Inc
12/01/202123:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EIDXEidos Therapeutics Inc
08/01/202108:02Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:EIDXEidos Therapeutics Inc
05/01/202108:31Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:EIDXEidos Therapeutics Inc
04/01/202123:30GlobeNewswire Inc.Leading Independent Proxy Advisory Firm ISS Recommends BridgeBio Pharma and Eidos Therapeutics Stockholders Vote “FOR” Pr...NASDAQ:EIDXEidos Therapeutics Inc
29/12/202023:31Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:EIDXEidos Therapeutics Inc
29/12/202008:31Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:EIDXEidos Therapeutics Inc
16/12/202001:31Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:EIDXEidos Therapeutics Inc
05/12/202009:35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:EIDXEidos Therapeutics Inc
14/11/202009:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:EIDXEidos Therapeutics Inc
11/11/202008:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:EIDXEidos Therapeutics Inc
05/11/202023:30GlobeNewswire Inc.BridgeBio Pharma, Inc. Reports Third Quarter 2020 Financial Results And Business UpdateNASDAQ:EIDXEidos Therapeutics Inc
03/11/202008:02Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:EIDXEidos Therapeutics Inc
31/10/202007:56Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:EIDXEidos Therapeutics Inc
30/10/202007:48Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:EIDXEidos Therapeutics Inc
30/10/202007:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:EIDXEidos Therapeutics Inc
30/10/202007:30GlobeNewswire Inc.Eidos Therapeutics Reports Third Quarter 2020 Financial Results and Business UpdateNASDAQ:EIDXEidos Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:EIDX